| Tozasertib |
ENSG00000126005.11 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000163364.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000170919.11 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000173867.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000175147.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000175611.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000177822.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000181097.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000181798.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000182057.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000182165.13 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000185904.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000186056.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000187156.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000188365.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000196756.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000196810.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000196960.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000203280.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000203593.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000203808.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000203886.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000204380.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000204625.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000204791.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000204791.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000204792.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000205181.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000205500.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000206176.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000206176.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000206195.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000213994.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000214145.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000215039.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000215068.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000215241.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000215808.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000215866.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000221817.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000222042.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000223462.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000223571.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000223576.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000223579.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000223660.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000223697.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000223697.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000223745.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000223784.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000223791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000223791.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000223834.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000223839.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000223956.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000223979.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000224031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000224081.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000224167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000224424.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000224707.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000224729.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000224789.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000224794.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000224888.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000224950.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000224977.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000225057.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000225083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000225083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000225113.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000225205.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000225302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000225335.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000225335.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000225377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000225490.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000225675.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000225703.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000225721.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000225761.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000225914.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000225945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000226009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000226088.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000226245.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000226367.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000226381.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000226465.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000226609.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000226673.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000226780.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000226853.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000226856.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000226862.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000226862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000226877.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000226883.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000226889.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000226899.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000226917.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000227006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000227017.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000227028.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000227107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000227192.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000227279.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000227297.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000227373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000227403.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000227477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000227484.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000227502.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000227542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000227544.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000227589.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000227674.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000227698.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000227719.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000227741.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000227857.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000227953.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000228113.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000228137.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000228150.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000228172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000228172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000228192.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000228265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000228369.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000228389.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000228526.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000228540.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000228573.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000228577.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000228784.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000228786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000228786.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000228802.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000228838.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000229021.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000229036.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000229065.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000229162.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000229214.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000229263.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000229311.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000229331.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000229368.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000229431.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000229531.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000229647.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000229666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000229688.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000229702.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000229807.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000229867.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000229867.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000229901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000229905.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000229912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000229955.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000229970.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000230046.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000230084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000230107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000230131.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000230337.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000230612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000230615.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000230695.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000230732.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000230753.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000230826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000230912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000230943.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000231073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000231125.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000231187.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000231188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000231193.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000231242.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000231298.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000231327.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000231346.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000231355.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000231407.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000231566.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000231566.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000231616.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000231709.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000231728.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000231903.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000232063.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000232065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000232077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000232082.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000232085.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000232093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000232104.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000232211.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000232412.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000232527.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000232527.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000232586.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000232586.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000232656.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000232677.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000232684.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000232855.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000233006.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000233009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000233016.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000233058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000233203.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000233242.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000233244.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000233355.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000233368.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000233452.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000233559.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000233621.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000233651.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000233694.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000233695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000233755.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000233757.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000233757.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000233785.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000233799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000233871.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000233895.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000234062.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000234076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000234171.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000234245.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000234323.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000234378.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000234405.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000234432.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000234432.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000234492.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000234694.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000234807.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000234902.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000234913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000235070.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000235078.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000235078.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000235119.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000235358.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000235387.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000235501.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000235652.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000235652.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000235660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000235724.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000235740.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000235781.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000235999.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000236008.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000236017.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000236088.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000236137.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000236166.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000236209.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000236345.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000236377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000236682.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000236700.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000236751.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000236753.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000236830.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000236861.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000236861.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000236869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000236871.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000236901.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000236990.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000236991.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000237021.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000237125.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000237248.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000237253.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000237298.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000237301.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000237331.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000237380.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000237689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000237705.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000237781.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000237781.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000237819.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000237870.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000238058.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000238078.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000238133.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000238279.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000238280.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000239415.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000239523.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000240057.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000240476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000240618.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000240859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000240875.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000241125.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000241163.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000241269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000241316.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000241990.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000242086.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000242136.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000242242.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000242282.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000242357.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000242396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000242791.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000243179.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000243415.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000243433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000243766.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000244040.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000244184.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000244198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000244265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000244306.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000244479.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000244586.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000244733.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000244945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000245059.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000245322.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000245522.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000245534.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000245552.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000246331.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000246523.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000246640.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000246740.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000246859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000247092.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000247363.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000247373.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000247373.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000247516.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000247774.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000247970.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000248008.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000248103.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000248131.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000248150.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000248360.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000248416.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000248554.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000248664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000248858.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000248858.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000248866.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000248896.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000248927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000248954.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000249084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000249198.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000249328.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000249348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000249436.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000249464.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000249572.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000249740.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000250073.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000250101.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000250131.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000250159.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000250295.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000250371.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000250404.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000250410.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000250659.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000250748.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000250765.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000250874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000250900.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000250948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000251127.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000251131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000251442.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000251555.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000251556.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000251629.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000253121.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000253167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000253339.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000253385.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000253408.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000253476.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000253535.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000253632.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000253669.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000253671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000253712.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000253736.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000253741.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000253878.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000253917.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000253921.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000253921.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000253926.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000253982.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000253982.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000254060.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000254094.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000254099.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000254154.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000254164.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000254177.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000254281.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000254389.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000254401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000254484.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000254554.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000254662.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000254694.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000254814.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000254842.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000254854.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000254859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000254869.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000254900.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000254911.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000254966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000254981.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000255045.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000255145.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000255165.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000255198.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000255247.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000255276.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000255343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000255348.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000255354.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000255474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000255495.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000256001.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000256150.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000256150.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000256234.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000256546.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000256576.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000256576.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000256603.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000256712.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000256940.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000256967.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000257058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000257126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000257135.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000257252.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000257475.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000257507.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000257556.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000257702.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000257735.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000257769.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000257900.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000257910.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000257931.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000258017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000258168.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000258268.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000258314.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000258317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000258410.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000258413.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000258437.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000258458.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000258553.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000258556.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000258558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000258616.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000258620.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000258633.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000258711.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000258725.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000258798.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000258825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000258843.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000258851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000258904.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000258935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000258940.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000258942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000258942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000259062.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000259065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000259198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000259225.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000259244.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000259251.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000259310.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000259438.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000259439.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000259448.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000259469.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000259499.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000259551.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000259595.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000259617.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000259652.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000259668.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000259687.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000259732.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000259772.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000259782.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000259786.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000259826.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000259877.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000259883.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000259883.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000259888.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000259915.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000260022.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000260032.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000260038.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000260081.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000260083.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000260136.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000260136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000260158.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000260281.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000260306.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000260360.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000260398.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000260409.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000260436.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000260439.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000260448.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000260475.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000260597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000260646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000260648.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000260661.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000260766.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000260787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000260796.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000260816.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000260895.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000260919.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000260936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000260938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000260941.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000260949.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000260971.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000260971.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000261043.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000261049.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000261094.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000261212.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000261251.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000261252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000261266.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000261266.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000261326.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000261327.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000261396.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000261433.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000261448.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000261469.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000261471.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000261488.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000261572.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000261574.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000261597.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000261613.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000261634.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000261693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000261712.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000261786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000261799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000261824.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000262020.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000262115.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000262165.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000262185.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000262188.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000262194.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000262228.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000262298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000262339.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000262434.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000262434.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000262823.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000262881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000262903.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000262951.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000262951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000263004.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000263105.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000263220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000263280.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000263327.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000263338.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000263400.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000263745.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000263847.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000263862.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000263884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000263931.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000264043.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000264270.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000264270.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000264304.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000264448.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000264575.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000264868.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000264932.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000264932.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000264940.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000265091.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000265148.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000265334.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000265349.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000265394.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000265443.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000265445.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000265490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000265780.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000265791.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000266236.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000266261.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000266473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000266942.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000266947.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000267004.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000267053.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000267053.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000267058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000267067.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000267082.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000267093.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000267143.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000267152.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000267191.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000267213.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000267249.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000267255.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000267268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000267298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000267322.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000267344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000267347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000267348.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000267394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000267395.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000267638.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000267658.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000267759.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000267808.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000267871.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000267886.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000267898.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000268119.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000268364.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000268458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000268536.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000268746.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000268987.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000269038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000269161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000269194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000269321.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000269399.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000269483.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000269834.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000269925.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000269934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000269938.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000269942.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000269951.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000269959.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000269961.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000269966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000269980.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000269997.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000270048.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000270062.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000270130.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000270145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000270177.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000270223.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000270361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000270557.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000270820.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000270933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000270949.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000271172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000271324.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000271327.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000271646.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000271659.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000271755.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000271788.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000271788.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000271825.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000271840.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000271840.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000271840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000271912.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000271983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000271993.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000272009.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000272102.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000272128.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000272129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000272138.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000272156.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000272172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000272254.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000272264.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000272327.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000272328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000272338.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000272346.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000272420.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000272461.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000272498.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000272508.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000272512.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000272518.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000272524.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000272524.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000272556.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000272562.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000272562.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000272564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000272627.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000272660.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000272689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000272695.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000272702.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000272764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000272859.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000272940.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000272966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000273056.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tozasertib |
ENSG00000273097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000273117.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000273203.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000273230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000273243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000273293.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000273309.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tozasertib |
ENSG00000273328.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000273350.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tozasertib |
ENSG00000273355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tozasertib |
ENSG00000273396.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tozasertib |
ENSG00000273402.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tozasertib |
ENSG00000273449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tozasertib |
ENSG00000273492.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
